{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:10:02Z","timestamp":1749010202137,"version":"3.41.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01669-4","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T08:46:10Z","timestamp":1748940370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heterochronic pelvic high-grade myxoinflammatory fibroblastic sarcoma and uterine endometroid carcinoma harboring common gene mutations: a rare case report with genomic analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Yuriko","family":"Higashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikumi","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Hisaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihide","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"1669_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1066896920958120","volume":"29","author":"M Libertini","year":"2021","unstructured":"Libertini M, Hallin M, Thway K, Noujaim J, Benson C, Van der Graaf W, et al. Gynecological sarcomas: molecular characteristics, behavior, and histology-driven therapy. Int J Surg Pathol. 2021;29:4\u201320.","journal-title":"Int J Surg Pathol"},{"key":"1669_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ygyno.2015.03.041","volume":"137","author":"LA Cantrell","year":"2015","unstructured":"Cantrell LA, Blank SV, Duska LR. Uterine carcinosarcoma: a review of the literature. Gynecol Oncol. 2015;137:581\u20138.","journal-title":"Gynecol Oncol"},{"key":"1669_CR3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/annonc\/mdw161","volume":"27","author":"K Matsuo","year":"2016","unstructured":"Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, et al. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma. Ann Oncol. 2016;27:1257\u201366.","journal-title":"Ann Oncol"},{"key":"1669_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jclinpath-2017-204787","volume":"71","author":"E Kuhn","year":"2018","unstructured":"Kuhn E, Ayhan A. Diagnostic immunohistochemistry in gynaecological neoplasia: a brief survey of the most common scenarios. J Clin Pathol. 2018;71:98\u2013109.","journal-title":"J Clin Pathol"},{"key":"1669_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/PGP.0000000000000346","volume":"36","author":"X Chen","year":"2017","unstructured":"Chen X, Arend R, Hamele-Bena D, Tergas AI, Hawver M, Tong GX, et al. Uterine carcinosarcomas: clinical, histopathologic and immunohistochemical characteristics. Int J Gynecol Pathol. 2017;36:412\u20139.","journal-title":"Int J Gynecol Pathol"},{"key":"1669_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jcp.55.5.321","volume":"55","author":"WG McCluggage","year":"2002","unstructured":"McCluggage WG. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? J Clin Pathol. 2002;55:321\u20135.","journal-title":"J Clin Pathol"},{"key":"1669_CR7","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3390\/cancers16233905","volume":"16","author":"MFP Maiorano","year":"2024","unstructured":"Maiorano MFP, Cormio G, Maiorano BA, Loizzi V. Uterine carcinosarcoma (UCS): a literature review and survival analysis from a retrospective cohort study. Cancers (Basel). 2024;16:3905.","journal-title":"Cancers (Basel)"},{"key":"1669_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","volume":"31","author":"AD Cherniack","year":"2017","unstructured":"Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, et al. Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell. 2017;31:411\u201323.","journal-title":"Cancer Cell"},{"key":"1669_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/10668969221088880","volume":"30","author":"I Kitazono","year":"2022","unstructured":"Kitazono I, Akahane T, Kobayashi Y, Yanazume S, Tabata K, Tasaki T, et al. Pelvic carcinosarcoma showing a diverse histology and hierarchical gene mutation with a common POLE mutation to endometrial endometroid carcinoma: a case report. Int J Surg Pathol. 2022;30:891\u20139.","journal-title":"Int J Surg Pathol"},{"key":"1669_CR10","unstructured":"Kim KR, Lax SF, Lazar AJ, Longacre TA, Malpica A, Matias-Guiu X, et al. Tumours of uterine corpus, in: WHO Classification of tumours editorial board, editors. Female Genital Tumours, 5th Edition. Lyon: IARC; 2020. p. 245\u2013308."},{"key":"1669_CR11","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67\u201373.","DOI":"10.1038\/nature12113"},{"key":"1669_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ygyno.2016.12.015","volume":"145","author":"JM Piulats","year":"2017","unstructured":"Piulats JM, Guerra E, Gil-Mart\u00edn M, Roman-Canal B, Gatius S, Sanz-Pamplona R, et al. Molecular approaches for classifying endometrial carcinoma. Gynecol Oncol. 2017;145:200\u20137.","journal-title":"Gynecol Oncol"},{"key":"1669_CR13","doi-asserted-by":"publisher","first-page":"153743","DOI":"10.1016\/j.prp.2021.153743","volume":"230","author":"I Kitazono","year":"2022","unstructured":"Kitazono I, Kobayashi Y, Akahane T, Yamaguchi T, Yanazume S, Nohara S, et al. ATM immunohistochemistry as a potential marker for the differential diagnosis of no specific molecular profile subtype and POLE-mutation subtype endometrioid carcinoma. Pathol Res Pract. 2022;230:153743.","journal-title":"Pathol Res Pract"},{"key":"1669_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1158\/1541-7786.MCR-21-0583","volume":"20","author":"EM Pinto","year":"2022","unstructured":"Pinto EM, Maxwell KN, Halalsheh H, Phillips A, Powers J, MacFarland S, et al. Clinical and functional significance of TP53 exon 4-intron 4 splice junction variants. Mol Cancer Res. 2022;20:207\u201316.","journal-title":"Mol Cancer Res"},{"key":"1669_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387:1094\u2013108.","journal-title":"Lancet"},{"key":"1669_CR16","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.3390\/cancers16233918","volume":"16","author":"M Albert\u00ed-Valls","year":"2024","unstructured":"Albert\u00ed-Valls M, Olave S, Olom\u00ed A, Maci\u00e0 A, Eritja N. Advances in immunotherapy for endometrial cancer: insights into MMR status and tumor microenvironment. Cancers (Basel). 2024;16:3918.","journal-title":"Cancers (Basel)"},{"key":"1669_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10147-024-02689-8","volume":"30","author":"A Jo","year":"2025","unstructured":"Jo A, Shoji T, Otsuka H, Abe M, Tatsuki S, Chiba Y, et al. Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors. Int J Clin Oncol. 2025;30:229\u201340.","journal-title":"Int J Clin Oncol"},{"key":"1669_CR18","doi-asserted-by":"crossref","unstructured":"Ribeiro-Santos P, Martins Vieira C, Viana Veloso GG, Vieira Giannecchini G, Arenhardt MP, L.M. Gomes LM, et al. Tailoring endometrial cancer treatment based on molecular pathology: current status and possible impacts on systemic and local treatment. Int J Mol Sci. 2024;25:7742.","DOI":"10.3390\/ijms25147742"},{"key":"1669_CR19","doi-asserted-by":"crossref","unstructured":"Laczmanska I, Michalowska D, Jedryka M, Blomka D, Semeniuk M, Czykalko E, et al, M. Fast and reliable Sanger POLE sequencing protocol in FFPE tissues of endometrial cancer. Pathol Res Pract. 2023;242:154315.","DOI":"10.1016\/j.prp.2023.154315"},{"key":"1669_CR20","doi-asserted-by":"publisher","first-page":"1610013","DOI":"10.3389\/pore.2021.1610013","volume":"27","author":"Y Kobayashi","year":"2021","unstructured":"Kobayashi Y, Kitazono I, Akahane T, Yanazume S, Kamio M, Togami S, et al. Molecular evaluation of endometrial dedifferentiated carcinoma, endometrioid carcinoma, carcinosarcoma, and serous carcinoma using a custom-made small cancer panel. Pathol Oncol Res. 2021;27:1610013.","journal-title":"Pathol Oncol Res"},{"key":"1669_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.prp.2007.05.008","volume":"203","author":"G Ferrandina","year":"2007","unstructured":"Ferrandina G, Zannoni GF, Martinelli E, Vellone V, Prisco MG, Scambia G. Endometrial carcinoma recurring as carcinosarcoma: report of two cases. Pathol Res Pract. 2007;203:677\u201381.","journal-title":"Pathol Res Pract"},{"key":"1669_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1447-0756.2008.00771.x","volume":"34","author":"R Shaco-Levy","year":"2008","unstructured":"Shaco-Levy R, Piura B. Endometrioid endometrial adenocarcinoma recurring as carcinosarcoma. J Obstet Gynaecol Res. 2008;34:279\u201382.","journal-title":"J Obstet Gynaecol Res"},{"key":"1669_CR23","first-page":"384","volume":"11","author":"EA Montgomery","year":"1998","unstructured":"Montgomery EA, Devaney KO, Giordano TJ, Weiss SW. Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin\u2019s disease, and various sarcomas. Mod Pathol. 1998;11:384\u201391.","journal-title":"Mod Pathol"},{"key":"1669_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/00000478-199808000-00001","volume":"22","author":"JM Meis-Kindblom","year":"1998","unstructured":"Meis-Kindblom JM, Kindblom LG. Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet. Am J Surg Pathol. 1998;22:911\u201324.","journal-title":"Am J Surg Pathol"},{"key":"1669_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0344-0338(98)80041-1","volume":"194","author":"M Michal","year":"1998","unstructured":"Michal M. Inflammatory myxoid tumor of the soft parts with bizarre giant cells. Pathol Res Pract. 1998;194:529\u201333.","journal-title":"Pathol Res Pract"},{"key":"1669_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAS.0b013e31829f3d85","volume":"38","author":"WB Laskin","year":"2014","unstructured":"Laskin WB, Fetsch JF, Miettinen M. Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome. Am J Surg Pathol. 2014;38:1\u201312.","journal-title":"Am J Surg Pathol"},{"key":"1669_CR27","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1038\/s41379-020-0580-6","volume":"33","author":"D Suster","year":"2020","unstructured":"Suster D, Michal M, Huang H, Ronen S, Springborn S, Debiec-Rychter M, et al. Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases. Mod Pathol. 2020;33:2520\u201333.","journal-title":"Mod Pathol"},{"key":"1669_CR28","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00264-013-2048-5","volume":"37","author":"R Lombardi","year":"2013","unstructured":"Lombardi R, Jovine E, Zanini N, Salone MC, Gambarotti M, Righi A, et al. A case of lung metastasis in myxoinflammatory fibroblastic sarcoma: analytical review of one hundred and thirty eight cases. Int Orthop. 2013;37:2429\u201336.","journal-title":"Int Orthop"},{"key":"1669_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.anndiagpath.2015.03.012","volume":"19","author":"M Michal","year":"2015","unstructured":"Michal M, Kazakov DV, Hadravsk\u00fd L, Kinkor Z, Kuroda N, Michal M. High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases. Ann Diagn Pathol. 2015;19:157\u201363.","journal-title":"Ann Diagn Pathol"},{"key":"1669_CR30","doi-asserted-by":"crossref","unstructured":"Srivastava P, Husain N, Neyaz A, Gupta V. Aggressive myxoinflammatory fibroblastic sarcoma with multiple site metastases. BMJ Case Rep. 2018;2018:bcr2018224259.","DOI":"10.1136\/bcr-2018-224259"},{"key":"1669_CR31","doi-asserted-by":"crossref","unstructured":"Karpathiou G, Devouassoux-Shisheboran M, Stolnicu S, Chauleur C, P\u00e9oc\u2019h M. Uterine inflammatory myofibroblastic tumor. Pathol Res Pract. 2023;242:154335.","DOI":"10.1016\/j.prp.2023.154335"},{"key":"1669_CR32","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.5858\/arpa.2013-0549-RS","volume":"138","author":"E Leremia","year":"2014","unstructured":"Leremia E, Thway K. Myxoinflammatory fibroblastic sarcoma: morphologic and genetic updates. Arch Pathol Lab Med. 2014;138:1406\u201311.","journal-title":"Arch Pathol Lab Med"},{"key":"1669_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.humpath.2016.02.005","volume":"53","author":"RT Zreik","year":"2016","unstructured":"Zreik RT, Carter JM, Sukov WR, Ahrens WA, Fritchie KJ, Montgomery EA, et al. TGFBR3 and MGEA5 rearrangements are much more common in \u201chybrid\u201d hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study. Hum Pathol. 2016;53:14\u201324.","journal-title":"Hum Pathol"},{"key":"1669_CR34","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.5858\/arpa.2017-0219-RA","volume":"141","author":"DR Lucas","year":"2017","unstructured":"Lucas DR. Myxoinflammatory fibroblastic sarcoma: review and update. Arch Pathol Lab Med. 2017;141:1503\u20137.","journal-title":"Arch Pathol Lab Med"},{"key":"1669_CR35","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/ijms25021127","volume":"25","author":"J Nishio","year":"2024","unstructured":"Nishio J, Nakayama S, Aoki M. Recent advances in the diagnosis, pathogenesis, and management of myxoinflammatory fibroblastic sarcoma. Int J Mol Sci. 2024;25:1127.","journal-title":"Int J Mol Sci"},{"key":"1669_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ygyno.2020.10.043","volume":"160","author":"S Matsuzaki","year":"2021","unstructured":"Matsuzaki S, Klar M, Matsuzaki S, Roman LD, Sood AK, Matsuo K. Uterine carcinosarcoma: contemporary clinical summary, molecular updates, and future research opportunity. Gynecol Oncol. 2021;160:586\u2013601.","journal-title":"Gynecol Oncol"},{"key":"1669_CR37","doi-asserted-by":"publisher","first-page":"e70132","DOI":"10.1096\/fj.202401991R","volume":"38","author":"MS Gopinatha Pillai","year":"2024","unstructured":"Gopinatha Pillai MS, Shaw P, Dey Bhowmik A, Bhattacharya R, Rao G, Dhar Dwivedi SK. Uterine carcinosarcoma: Unraveling the role of epithelial-to-mesenchymal transition in progression and therapeutic potential. FASEB J. 2024;38:e70132.","journal-title":"FASEB J"},{"key":"1669_CR38","doi-asserted-by":"publisher","first-page":"e108647","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40:e108647.","journal-title":"EMBO J"},{"key":"1669_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41419-023-06032-3","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, Liu Y, Liu S. The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion. Cell Death Dis. 2023;14:506.","journal-title":"Cell Death Dis"},{"key":"1669_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12964-023-01207-z","volume":"21","author":"A Oh","year":"2023","unstructured":"Oh A, Pardo M, Rodriguez A, Yu C, Nguyen L, Liang O, et al. NF-\u03baB signaling in neoplastic transition from epithelial to mesenchymal phenotype. Cell Commun Signal. 2023;21:291.","journal-title":"Cell Commun Signal"},{"key":"1669_CR41","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1038\/onc.2012.334","volume":"32","author":"P Dong","year":"2013","unstructured":"Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, et al. Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene. 2013;32:3286\u201395.","journal-title":"Oncogene"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01669-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T08:46:14Z","timestamp":1748940374000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01669-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1669"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01669-4","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of the clinical samples was approved by the Ethics Committee for Clinical and Epidemiologic Research of Kagoshima University (approval no. 180215) and the study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript is not submitted for publication or consideration elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}